ArticleJAMA network open2022

Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era.

Nayan Lamba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.